Therapeutic mTOR inhibition in autosomal dominant polycystic kidney disease: What is the appropriate serum level?

G. Canaud, B. Knebelmann, P. C. Harris, F. Vrtovsnik, J. M. Correas, N. Pallet, C. M. Heyer, E. Letavernier, F. Bienaimé, E. Thervet, F. Martinez, F. Terzi, C. Legendre

Research output: Contribution to journalArticlepeer-review

46 Scopus citations

Fingerprint

Dive into the research topics of 'Therapeutic mTOR inhibition in autosomal dominant polycystic kidney disease: What is the appropriate serum level?'. Together they form a unique fingerprint.

Medicine & Life Sciences